Approved Study Database

Ref. No. Scientific Title Principal investigator
2009.403 The ATACAS Trial: Aspirin and Tranexamic Acid for Coronary Artery Surgery Trial Dr. CHAN Matthew Tak Vai
2013.319 REstrictive versus LIbEral Fluid Therapy in Major Abdominal Surgery (RELIEF) Trial Dr. CHAN Matthew Tak Vai
2010.017 Perioperative Ischemic Evaluation-2 (POISE-2) Dr Chan Matthew Tak Vai
2010.006 A Prospective Study of the Effects of Pregabalin versus Placebo on the incidence and intensity of pain after thoracoscopic surgery Dr CHAN Matthew Tak Vai
2012.414 Management of myocardial injury After NoncArdiac surGEry Trial Dr CHAN Matthew Tak Vai
2012.197 Cognitive Function after Nitrous Oxide Anesthesia: A randomized Controlled Trial Dr Chan Matthew Tak Vai
2018.537 Perioperative Ischemic Evaluation (POISE) – 3 Trial Dr. CHAN Matthew Tak Vai
陳德威
2020.209 COVID Airway Provider PPE Use and Outcomes Registry Dr. CHAN Matthew Tak Vai
陳德威
2020.368 Postoperative vascular complications in unrecognized Obstructive Sleep Apnea (POSA) - II trial: Effect of Nasal High-Flow therapy in Major Noncardiac Surgery Dr. CHAN Matthew Tak Vai
陳德威
2019.640 COlchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF) Dr. CHAN Matthew Tak Vai
陳德威
2017.069 Reduction Of Chronic Post-surgical Pain with Ketamine (ROCKet) Trial Dr. CHAN Matthew Tak Vai
陳德威
2016.723 PeRioperative HypOThErmia and myoCardial injury afTer non-cardiac surgery (PROTECT) Trial Dr. CHAN Matthew Tak Vai
陳德威
2015.355 Targeting Anesthetic Depth to Prevent Postoperative Delirium: A Randomized Controlled Trial Dr. CHAN Matthew Tak Vai
陳德威
2015.356 The Perioperative Administration of Dexamethasone And blood Glucose concentrations Trial Dr. CHAN Matthew Tak Vai
陳德威
2014.672 Detection and characterization of novel / unrecognized microbial pathogens associated with unexplained severe sepsis Dr. CHAN Matthew Tak Vai
2016.526 Perioperative Atrial Fibrillation and Postoperative Stroke Dr. CHAN Matthew Tak Vai
陳德威
2014.684 Perioperative Administration of Dexamethasone and Infection Trial Dr. CHAN Matthew Tak Vai
2021.612 Tight perioperative blood pressure management to reduce serious cardiovascular, renal, and cognitive complications Dr. CHAN Matthew Tak Vai
陳德威
2020.652 The SNaPP Pilot Trial: Sugammadex, Neostigmine and Postoperative Pulmonary Complications Dr. CHAN Matthew Tak Vai
陳德威
2023.077 The SNaPP Study: Sugammadex, Neostigmine and Postoperative Pulmonary Complications Dr. CHAN Matthew Tak Vai
2021.486 Depth of anaesthesia and long-term survival in elderly surgical patients: a protocol for the Balanced randomised controlled trial long term follow up study Dr. CHAN Matthew Tak Vai
陳德威
2023.090 Neurological Impact of CerebroVascular Events In Noncardiac Surgery Patients (NeuroVISION) – 2 Study Dr. CHAN Matthew Tak Vai
Matthew Chan
2021.086 Long-term Outcomes of Lidocaine Infusions for persistent PostOperative Pain in patients undergoing breast surgery: The LOLIPOP Trial Dr. CHAN Matthew Tak Vai
陳德威
2018.558 IV iron for Treatment of Anaemia before Cardiac Surgery Dr. CHAN Matthew T.V.
陳德威
2013.182 Vascular events In Surgery patIents cOhort evaluatioN – Cardiac Surgery Dr. CHAN Matthew T.V.
2024.022 The role of cardiopulmonary capacity in postoperative morbidity and mortality after major surgery Prof. CHAN Matthew T. V.
陳德威
2024.375 User-Testing Protocol for the Cloud DX Vitaliti Continuous Vital Signs Monitor (Model CVSM-1A) for Clinical Use and Self Measurement in Ambulatory Settings Professor Chan Matthew
Matthew Chan
2024.370 Preserving brain health after surgery: does light general anaesthesia reduce postoperative delirium and cognitive decline compared with deep general anaesthesia in older adults? The Balanced-2 Study Dr Chan Matthew
Matthew Chan
2024.374 Functional Assessment for Surgery by a Timed Walk (FAST Walk) Professor Chan Matthew
陳德威
2013.546 Cultural Influences of Postoperative Pain Dr. CHAN Matthew
2008.219 The Role of Endothelial Dysfunction in Postoperative Cardiac Complications Dr Chan Matthew
2014.045 International Surgical Outcomes Study Dr Chan Matthew
2008.285 A Prospective Cohort Analysis of Opioid Effectiveness and Sensitivity in a Group of Chinese and Australian Patients Having Major Surgery Dr Chan Matthew
2013.008 Laboratory study of tissue tropism of human norovirus within and beyond digestive tract using archived norovirus-containing clinical stool specimens Dr CHAN Martin Chi-wai
2013.239 Laboratory discovery of novel viruses associated with acute neurological illness using residual routine cerebrospinal fluid specimens of unknown etiology Dr. CHAN Martin Chi Wai
2013.330 Laboratory detection of novel norovirus strain(s) using residual routine diagnostic stool specimens Dr. CHAN Martin Chi Wai
2014.115 Laboratory study of binding characteristics of native norovirus and synthetic norovirus-like particles Dr. CHAN Martin Chi Wai
2014.141 Genetic Susceptibility of Hong Kong Ethnic Chinese to Severe Influenza and RSV Infections Dr. CHAN Martin Chi Wai
2016.052 Host interactome of human norovirus structural proteins Dr. CHAN Martin Chi Wai
陳子蔚
2016.167 Virus Genotype Distribution of Local Hepatitis E Virus Infection Dr. CHAN Martin Chi Wai
陳子蔚
2017.088 Characteristics and Clinical Relevance of Microbiome Changes in Severe Influenza and Respiratory Syncytial Virus Infection Dr. CHAN Martin Chi Wai
陳子蔚
2017.130 Genome-wide CRISPR screen for host factors associated with norovirus infections in stem cell-derived human intestinal enteroid model Dr. CHAN Martin Chi Wai
陳子蔚
2015.110 A 40-year-old question – what is the functional receptor for human norovirus? Dr. CHAN Martin Chi Wai
陳子蔚
2016.516 Replication Kinetics of Different Norovirus Genotypes and Haplotypes in Stem Cell-derived Human Intestinal Enteroid Culture Dr. CHAN Martin Chi Wai
陳子蔚
2017.054 Identification of novel/unrecognized viruses associated with unexplained severe acute respiratory illnesses Dr. CHAN Martin Chi Wai
陳子蔚
2015.268 Clinical and Virological Characterization of the Novel Norovirus GII.17 Hong Kong 2014 Dr. CHAN Martin Chi Wai
陳子蔚
2016.170 Global Distribution of the Emergent Norovirus Genogroup II Genotype 17 Kawasaki 2014 Variant Dr. CHAN Martin Chi Wai
陳子蔚
2015.558 Role of host genetic factors in hospitalized norovirus gastroenteritis Dr. CHAN Martin Chi Wai
陳子蔚
2016.445 Evaluation of an Early Alert and Research Platform for Seasonal and Atypical Local Norovirus Activity (Noro-EAR) via Rapid Sequence-based Genomic Molecular Typing Dr. CHAN Martin Chi Wai
陳子蔚
2017.216 Use of Next-generation Sequencing to Identify New Intestinal Viruses Associated with Unexplained Acute Gastroenteritis Dr. CHAN Martin Chi Wai
陳子蔚

Page 204 of 265.